Before the COVID-19 pandemic, retail current value sales of digestive remedies benefited from consumer preferences shifting towards preventative health. However, after the initial panic caused by the outbreak of COVID-19 in the spring of 2020, demand for digestive remedies declined, with H2 blockers particularly weak. The latter was a consequence of the recall of Zantac in 2019 due to a finding that levels of a cancer-causing chemical called N-Nitrosodimethylamine increased over time in the drug...

Euromonitor International’s Digestive Remedies in Ireland report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2016-2020, allowing you to identify the sectors driving growth. Forecasts to 2025 illustrate how the market is set to change.

Product coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.


Why buy this report?
* Get a detailed picture of the Digestive Remedies market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years’ experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.